LAIR2 and neoplasm: Since the majority of LAIR2+ cells within TILs derived from CD4+ T cells, we queried the scRNASeq dataset by comparing the expression profile of CD4+LAIR2+ cells with that of CD4+LAIR2− cells within the tumor-infiltrating fraction.